146 related articles for article (PubMed ID: 627180)
21. Pilot study of a novel treatment for androgenetic alopecia using enriched cell culture medium: clinical trials.
Lindenbaum ES; Feitelberg AL; Tendler M; Beach D; Gamliel-Lazarovich A; Har-Shai Y; Hirshowitz B
Dermatol Online J; 2003 Feb; 9(1):4. PubMed ID: 12639462
[TBL] [Abstract][Full Text] [Related]
22. [Hair growth disorders following sex hormone treatment--therapy of hair growth disorders using sex hormones].
Zaun H
Hautarzt; 1973 Jan; 24(1):1-6. PubMed ID: 4121384
[No Abstract] [Full Text] [Related]
23. [Assessment of efficacy of Diane-35 in androgenetic feminine alopecia].
Brzezińska-Wcisło L
Wiad Lek; 2003; 56(3-4):202-5. PubMed ID: 12923971
[TBL] [Abstract][Full Text] [Related]
24. Hair loss in women.
Tosti A; Piraccini BM; Sisti A; Duque-Estrada B
Minerva Ginecol; 2009 Oct; 61(5):445-52. PubMed ID: 19749676
[TBL] [Abstract][Full Text] [Related]
25. [Dermatologic complications of oral hormonal contraception (Gravistat)].
Mikrut W
Wiad Lek; 1986 Nov; 39(21):1462-5. PubMed ID: 3577158
[TBL] [Abstract][Full Text] [Related]
26. [Systematic treatment with sex hormones in dermatology].
Zaun H
Aktuelle Derm; 1976 Feb; 2(1):33-8. PubMed ID: 12308225
[TBL] [Abstract][Full Text] [Related]
27. [Hair-growth disorders in relation to pregnancy and hormonal contraception].
Zaun H
Z Geburtshilfe Perinatol; 1973 Apr; 177(2):67-73. PubMed ID: 4578114
[No Abstract] [Full Text] [Related]
28. [Clinical use of ethinyl estradiol in combination with cyproterone acetate. Study based on 50 cases (author's transl)].
Henrion R; Laveissiere MN
Contracept Fertil Sex (Paris); 1982 Oct; 10(10):653-7. PubMed ID: 12338447
[TBL] [Abstract][Full Text] [Related]
29. Alopecia due to high androgen index contraceptives.
Graves KY; Smith BJ; Nuccio BC
JAAPA; 2018 Aug; 31(8):20-24. PubMed ID: 29979329
[TBL] [Abstract][Full Text] [Related]
30. [Advantages and risks of hormonal contraception].
Mall-Haefeli M
Fortschr Med; 1982 Apr; 100(16):723-8. PubMed ID: 7084860
[TBL] [Abstract][Full Text] [Related]
31. [Dermal changes in response to hormonal contraceptives (author's transl)].
Scholz C; Donat H
Zentralbl Gynakol; 1981; 103(19):1158-64. PubMed ID: 6458978
[TBL] [Abstract][Full Text] [Related]
32. [Study of the effect of vinblastine on hair growth in rats].
Brzezińska-Wcisło L
Przegl Dermatol; 1990; 77(1):14-9. PubMed ID: 2382011
[TBL] [Abstract][Full Text] [Related]
33. Oral contraception.
Helles AA
Arch Pharm Chem (Kbh); 1971; 78():2-9. PubMed ID: 12334380
[TBL] [Abstract][Full Text] [Related]
34. Alopecia from oral contraceptives.
Cormia FE
JAMA; 1967 Aug; 201(8):635-7. PubMed ID: 4143753
[No Abstract] [Full Text] [Related]
35. Value of hormonal levels in patients with male androgenetic alopecia treated with finasteride: better response in patients under 26 years old.
Camacho FM; García-Hernández MJ; Fernández-Crehuet JL
Br J Dermatol; 2008 May; 158(5):1121-4. PubMed ID: 18363752
[TBL] [Abstract][Full Text] [Related]
36. [The pill and endocrine diseases].
Werner-Zodrow I; Staub JJ
Gynakol Rundsch; 1978; 18(3-4):246-52. PubMed ID: 569627
[TBL] [Abstract][Full Text] [Related]
37. Comparison of the efficacy and safety of topical minoxidil and topical alfatradiol in the treatment of androgenetic alopecia in women.
Blume-Peytavi U; Kunte C; Krisp A; Garcia Bartels N; Ellwanger U; Hoffmann R
J Dtsch Dermatol Ges; 2007 May; 5(5):391-5. PubMed ID: 17451383
[TBL] [Abstract][Full Text] [Related]
38. [Oral contraception and hypertension].
Janssens J; Dijkstra JC
Ned Tijdschr Geneeskd; 1976 Dec; 120(49):2166-8. PubMed ID: 1012375
[TBL] [Abstract][Full Text] [Related]
39. Diagnosing and treating hair loss.
Mounsey AL; Reed SW
Am Fam Physician; 2009 Aug; 80(4):356-62. PubMed ID: 19678603
[TBL] [Abstract][Full Text] [Related]
40. [Editorial: The contraceptive pill and loss of hair].
Haim S
Harefuah; 1974 Jan; 86(3):155-6. PubMed ID: 4828249
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
